Radiopharmaceuticals: all 1,299 studies that test it
Page 3 of 13. Open to participants first (296), then studies with results posted, then the rest; newest registration first within each.
- Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine TumorsRecruitingNCT05687123Phase 1
- Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCRecruitingNCT05668962Phase 2
- [18F]PI-2620 Phase 3 Histopathological StudyRecruitingNCT05641688Phase 3
- Hyperpolarized 13C MRI as a Biomarker in Advanced Solid TumorsRecruitingNCT05599048Phase 1/2
- 68Ga-N188 PET/CT Imaging in MalignancyRecruitingNCT05593107Not applicable
- SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral TherapyRecruitingNCT05586581Phase 1/2
- Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell CancerRecruitingNCT05583708Phase 2
- An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung CancerRecruitingNCT05558904Phase 1/2
- A Safety Study of 212Pb-Pentixather Radioligand TherapyNot yet recruitingNCT05557708Early Phase 1
- Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGGRecruitingNCT05555550Early Phase 1
- Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain MetastasisRecruitingNCT05554302Phase 2
- 18F-Fluciclovine PET-MRI in High-grade GliomaRecruitingNCT05553041Early Phase 1
- 68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer PatientsRecruitingNCT05543954Early Phase 1
- 18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028RecruitingNCT05520255Phase 3
- MIBG in Aging and Neurologic DisordersEnrolling by invitationNCT05514106Phase 4
- 68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational StudiesRecruitingNCT05506566Phase 1/2
- [68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid TumorsRecruitingNCT05490264Early Phase 1
- Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial CancerRecruitingNCT05446324Phase 3
- Collagen-targeted PET Imaging for Early Interstitial Lung DiseaseRecruitingNCT05417776Phase 2
- Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer PatientsEnrolling by invitationNCT05396118Phase 2
- Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)RecruitingNCT05371132Phase 1
- Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple MyelomaRecruitingNCT05363111Phase 1
- Assess Fibrin in Brains With AD/ADRDRecruitingNCT05336695Phase 1/2
- First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET ImagingRecruitingNCT05335811Phase 1
- 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer PatientsRecruitingNCT05324332Not applicable
- Lutathera for Treatment of Recurrent or Progressive High-Grade CNS TumorsRecruitingNCT05278208Phase 1/2
- FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown PrimaryRecruitingNCT05263700Not applicable
- CXCR4-targeted PET/CT Imaging in Hematological MalignanciesRecruitingNCT05255926Not applicable
- Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic CancersRecruitingNCT05204147Phase 1
- PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPIRecruitingNCT05172310Phase 1
- 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation TherapyRecruitingNCT05155046Phase 2
- TES RCT Fleet Enema vs Oral Mechanical Bowel PrepRecruitingNCT05148494Phase 4
- Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral AdiposityRecruitingNCT05147909Not applicable
- Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CTRecruitingNCT05121779Phase 1
- Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate CancerRecruitingNCT05113537Phase 1/2
- Evaluation of CCR2 in Patients Post Myocardial InfarctionRecruitingNCT05107596Phase 1
- In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PETRecruitingNCT05093335Early Phase 1
- Utility of 18FDOPA PET/MRI for Focal HyperinsulinismRecruitingNCT05088798Phase 2
- 18F-MFBG PET/CT in the Evaluation of Neural Crest TumorRecruitingNCT05069220Early Phase 1
- Clinical Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease PatientsRecruitingNCT05043675Early Phase 1
- Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast CancerRecruitingNCT05042687Not applicable
- 68Ga-FAPI PET/CT in Malignant TumorsRecruitingNCT05034146Not applicable
- Choline-PET: Exploratory Study Assessing the Potential Role of F-choline PET Imaging in New and Emerging IndicationsRecruitingNCT04999215Phase 3
- Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotideRecruitingNCT04997317Phase 1/2
- [18F]PT2385 PET/CT in Patients With Renal Cell CarcinomaRecruitingNCT04989959Phase 1
- The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting InsulinomaRecruitingNCT04979611Phase 1
- Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular CarcinomaRecruitingNCT04965454Phase 2
- Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NETRecruitingNCT04954820Phase 2
- Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate CancerRecruitingNCT04946370Phase 1/2
- A Study of 177Lu-FAP-2286 in Advanced Solid TumorsRecruitingNCT04939610Phase 1/2
- 177Lutetium-DOTATATE in Children with Primary Refractory or Relapsed High-risk NeuroblastomaRecruitingNCT04903899Phase 2
- 68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive TumorsRecruitingNCT04888481Phase 2
- Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin LymphomaRecruitingNCT04871607Phase 2
- 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)RecruitingNCT04868604Phase 1/2
- 68Ga-PSMA-11 PET/CT in Patients With Various Types of CancerRecruitingNCT04831541Early Phase 1
- 68Ga-FAPI PET/CT in Patients With Various Fibrotic DiseaseRecruitingNCT04831034Early Phase 1
- Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating GliomasRecruitingNCT04772456Phase 1
- 18F-DOPA II - PET Imaging OptimizationRecruitingNCT04706910Phase 3
- Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic RadiosurgeryRecruitingNCT04689048Phase 1
- Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine TumorsRecruitingNCT04665739Phase 2
- Imaging of Solid Tumors Using FAP-2286RecruitingNCT04621435Phase 1
- New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)RecruitingNCT04600115Early Phase 1
- 68Ga-ICAM-1pep PET/CT in Cancer PatientsRecruitingNCT04596670Early Phase 1
- An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic TherapyRecruitingNCT04589624Phase 1
- PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)RecruitingNCT04582916Phase 1
- Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade GliomaRecruitingNCT04540107Phase 1
- 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast CancerRecruitingNCT04529044Phase 2
- Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell LymphomaRecruitingNCT04512716Early Phase 1
- Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative DiseasesRecruitingNCT04504526Early Phase 1
- Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue InjuryRecruitingNCT04485286Phase 2
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain DiseaseRecruitingNCT04396873Phase 1
- Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial ImagingRecruitingNCT04275453Phase 1/2
- [18F]F-DOPA Imaging in Patients With Autonomic FailureRecruitingNCT04246437Phase 1
- Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant DiseasesRecruitingNCT04083183Phase 1/2
- Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation TherapyRecruitingNCT04082520Phase 2
- Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active SurveillanceRecruitingNCT03933670Phase 2
- Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsRecruitingNCT03924466Phase 2
- Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CTRecruitingNCT03861676Early Phase 1
- Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma PatientsRecruitingNCT03832127Phase 1
- Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain TumorsRecruitingNCT03830151Phase 1
- Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's DiseaseRecruitingNCT03821857Phase 4
- Imaging Sex Differences in Smoking-Induced Pulmonary InflammationRecruitingNCT03721822Phase 1
- 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic SyndromeRecruitingNCT03670966Phase 1/2
- Feasibility of FMISO in Brain TumorsRecruitingNCT03649880Phase 2
- Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis PatientsRecruitingNCT03535545Phase 1
- Imaging of Traumatic Brain Injury Metabolism Using Hyperpolarized Carbon-13 PyruvateEnrolling by invitationNCT03502967Early Phase 1
- Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial Metastasis Treated With (SRS)RecruitingNCT03324360Phase 1
- Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal StudyRecruitingNCT02740634Not applicable
- A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear PalsyRecruitingNCT02605785Not applicable
- Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate CancerRecruitingNCT02526368Early Phase 1
- Fluorodopa F 18 in Congenital Hyperinsulinism and InsulinomaRecruitingNCT02021604Phase 1
- Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing SyndromeRecruitingNCT02019706Phase 2
- Longitudinal Multi-Modality Imaging in Progressive Apraxia of SpeechRecruitingNCT01818661Phase 4
- DaTSCAN Imaging in Aging and Neurodegenerative DiseaseEnrolling by invitationNCT01453127Phase 4
- Imaging of Brain Amyloid Plaques in the Aging PopulationEnrolling by invitationNCT00950430Phase 4
- Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or ParagangliomaRecruitingNCT00107289Phase 2
- Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical ProstatectomyCompletedNCT06604442Phase 4Results posted
- Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid LoadCompletedNCT05968846Phase 2Results posted
- Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical ProstatectomyActive, not recruitingNCT05678322Phase 3Results posted
- Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate CancerCompletedNCT05653856Phase 2Results posted